← All trials
NCT00509275
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2007
- Primary completion
- Aug 1, 2008
- Completion date
- Aug 1, 2008
- First posted
- —
- Last posted
- —
- Enrollment
- 120
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- Stiefel LaboratoriesLead sponsor
- South East Dermatology, South East Dermatology, Carina QLD 4152, AustraliaOverall official - principal investigator
- Skin and Cancer Foundation, Carlton, AustraliaOverall official - principal investigator
- St. George Hospital, KogarahOverall official - principal investigator
- The Skin Centre, Benowa, AustraliaOverall official - principal investigator
- International Dermatology Research Inc.Overall official - principal investigator
- University of AdelaideOverall official - principal investigator
- University of CincinnatiOverall official - principal investigator
- NewLab Clinical ResearchOverall official - principal investigator
- Dermatology Specialists, LouisvilleOverall official - principal investigator
- GlaxoSmithKlineCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.